BPC-157 × luxaralabs.com — lab test, February 2026
This lab doesn't publish a public lookup, so we can't confirm the certificate against the lab's own record. The document was reviewed before publication, but it rests on our review alone.
What portal verification means →Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 80 mg · Lab measured 92.86 mg
116% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 23.2 mg using the measured mass, against 20 mg on the label — 16% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | K80665 |
|---|---|
| Portal lookup | Lab has no portalThis laboratory publishes no public lookup, so the report cannot be confirmed independently. |
| PDF vs portal | Testides's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of BPC-157/TB-500/GHK-Cu/KPV from luxaralabs.com, performed by Testides on February 4, 2026. Reported purity: 99.72%. Net content: 92.86 mg against 80 mg labeled (116% of label). Tested content exceeds the labeled amount by 16%. Batch K80665. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of BPC-157 from luxaralabs.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| GL7095 | 19 Feb 2026 | Testides | 99.53% | 119% | Lab has no portal |
| B11878 | 5 Feb 2026 | Testides | 99.15% | 110% | Lab has no portal |
| BT1209 - 10/10 | 5 Feb 2026 | Testides | 99.92% | 109% | Lab has no portal |
| BT7113 - 5/5 | 5 Feb 2026 | Testides | 99.95% | 111% | Lab has no portal |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion